Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events

Bierzynska, 2018, Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances, Pediatr Nephrol, 33, 2027, 10.1007/s00467-017-3793-2

Palygin, 2016, Protease-activated receptors in kidney disease progression, Am J Physiol Renal Physiol, 311, F1140, 10.1152/ajprenal.00460.2016

Harris, 2013, Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1, J Pathol, 229, 660, 10.1002/path.4149

Bierzynska, 2017, Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management, Kidney Int, 91, 937, 10.1016/j.kint.2016.10.013

Oleinika, 2019, Effector and regulatory B cells in immune-mediated kidney disease, Nat Rev Nephrol, 15, 11, 10.1038/s41581-018-0074-7

May, 2019, Human Th17 cells produce a soluble mediator that increases podocyte motility via signalling pathways which mimic PAR-1 activation, Am J Physiol Renal Physiol, 317, F913, 10.1152/ajprenal.00093.2019

Dryer, 2010, TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology, Am J Physiol Renal Physiol, 299, F689, 10.1152/ajprenal.00298.2010

Hall, 2019, TRPC channels in proteinuric kidney diseases, Cells, 9, 44, 10.3390/cells9010044

Riehle, 2016, TRPC6 G757D loss-of-function mutation associates with FSGS, J Am Soc Nephrol, 27, 2771, 10.1681/ASN.2015030318

Guan, 2017, A protease-activated receptor-1 antagonist protects against podocyte injury in a mouse model of nephropathy, J Pharmacol Sci, 135, 81, 10.1016/j.jphs.2017.09.002

Hammes, 1999, Shutoff and agonist-triggered internalization of protease-activated receptor 1 can be separated by mutation of putative phosphorylation sites in the cytoplasmic tail, Biochemistry, 38, 9308, 10.1021/bi9902236

Gallon, 2012, Resolution of recurrent focal segmental glomerulosclerosis after retransplantation, N Engl J Med, 366, 1648, 10.1056/NEJMc1202500

Ni, 2012, Podocyte culture: tricks of the trade, Nephrology (Carlton), 17, 525, 10.1111/j.1440-1797.2012.01619.x

Varghese, 2014, IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples, PLoS One, 9, 10.1371/journal.pone.0096801

Foster, 2008, Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium, Am J Pathol, 173, 938, 10.2353/ajpath.2008.070416

Yao, 2017, Smad2 and Smad3 play differential roles in the regulation of matrix deposition-related enzymes in renal mesangial cells, Int J Clin Exp Med, 10, 10161

Kellenberger, 2013, Differential effects of Smad3 targeting in a murine model of chronic kidney disease, Physiol Rep, 1, 10.1002/phy2.181

López-Colomé, 2017, a crossroad in pathological cell migration, J Hematol Oncol, 10, 50, 10.1186/s13045-017-0418-y

Welsh, 2011, The podocyte cytoskeleton—key to a functioning glomerulus in health and disease, Nat Rev Nephrol, 8, 14, 10.1038/nrneph.2011.151

Scheuble, 2020, Pharmacological and genetic inhibition of TRPC6-induced gene transcription, Eur J Pharmacol, 886, 10.1016/j.ejphar.2020.173357

Foster, 2009, Flufenamic acid is a tool for investigating TRPC6-mediated calcium signalling in human conditionally immortalised podocytes and HEK293 cells, Cell Calcium, 45, 384, 10.1016/j.ceca.2009.01.003

Farmer, 2019, TRPC6 binds to and activates calpain, independent of its channel activity, and regulates podocyte cytoskeleton, cell adhesion, and motility, J Am Soc Nephrol, 30, 1910, 10.1681/ASN.2018070729

Wang, 2019, Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice, Kidney Int, 95, 321, 10.1016/j.kint.2018.09.026

Singh, 2007, Galphaq-TRPC6-mediated Ca2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin, J Biol Chem, 282, 7833, 10.1074/jbc.M608288200

Chesor

Chin, 2003, Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability, Proc Natl Acad Sci U S A, 100, 11104, 10.1073/pnas.1831452100

Cunningham, 2000, Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis, J Exp Med, 191, 455, 10.1084/jem.191.3.455

Waasdorp, 2016, Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice, Sci Rep, 6, 10.1038/srep33030

Sharma, 2017, Thrombin-induced podocyte injury is protease-activated receptor dependent, J Am Soc Nephrol, 28, 2618, 10.1681/ASN.2016070789

Kistler, 2010, Enzymatic disease of the podocyte, Pediatr Nephrol, 25, 1017, 10.1007/s00467-009-1425-1

Liu, 2011, Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome, Clinical Immunol, 139, 314, 10.1016/j.clim.2011.02.018